Related Experiment Videos
Coagulation changes in sensitized canine renal allografts
The British Journal of Surgery
|January 1, 1977
Summary
Hyperacute rejection in canine kidney transplants involves intravascular coagulation, peaking early after revascularization. While some treatments reduced coagulation severity, they did not extend kidney graft survival beyond 24 hours.
Area of Science:
- Nephrology
- Immunology
- Transplantation Science
Background:
- Hyperacute rejection remains a significant challenge in organ transplantation.
- Understanding early coagulation events is crucial for improving graft survival.
Purpose of the Study:
- To investigate coagulation changes in canine kidney homotransplants during hyperacute rejection.
- To assess the efficacy of immunosuppressive and anticoagulant therapies in mitigating rejection and prolonging graft survival.
Main Methods:
- Studied arteriovenous gradients of blood elements and coagulation factors across kidney grafts in sensitized dogs.
- Administered treatments including cytotosine arabinoside, methylprednisolone, heparin, and azathioprine.
- Monitored graft function and evidence of intravascular coagulation.
Main Results:
- Confirmed intravascular coagulation within the graft during hyperacute rejection.
- Intravascular coagulation was most severe within the first 20 minutes post-revacularization.
- Therapeutic interventions partially reduced coagulation severity in some cases.
- No treatment extended kidney graft survival beyond 24 hours.
Conclusions:
- Hyperacute rejection in this model is characterized by early and severe intravascular coagulation.
- Current therapeutic strategies were insufficient to overcome the rapid rejection process and prolong graft survival.